These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15155188)

  • 1. The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation.
    Bland MV; Ismail S; Heinemann JA; Keenan JI
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1983-8. PubMed ID: 15155188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].
    González C; García A; Daroch F; Kawaguchi F; Solar H; Rivera N; Vega E
    Rev Med Chil; 2001 Jun; 129(6):643-6. PubMed ID: 11510204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.
    Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC; Dubini F
    J Chemother; 1996 Feb; 8(1):52-4. PubMed ID: 8835109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics.
    Marcus EA; Sachs G; Scott DR
    Aliment Pharmacol Ther; 2015 Oct; 42(7):922-33. PubMed ID: 26238858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro.
    Vogt K; Rodloff AC; Hahn H
    Infection; 1991; 19(3):138-9. PubMed ID: 1832417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriostatic and bactericidal activity of ranitidine bismuth citrate in Helicobacter pylori clinical isolates.
    Alarcón T; Domingo D; Prieto N; López-Brea M
    Rev Esp Quimioter; 1999 Mar; 12(1):64-8. PubMed ID: 10209056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimicrobial effects and metabolomic footprinting of carboxyl-capped bismuth nanoparticles against Helicobacter pylori.
    Nazari P; Dowlatabadi-Bazaz R; Mofid MR; Pourmand MR; Daryani NE; Faramarzi MA; Sepehrizadeh Z; Shahverdi AR
    Appl Biochem Biotechnol; 2014 Jan; 172(2):570-9. PubMed ID: 24104691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histochemical tracing of bismuth in Helicobacter pylori after in vitro exposure to bismuth citrate.
    Stoltenberg M; Martiny M; Sørensen K; Rungby J; Krogfelt KA
    Scand J Gastroenterol; 2001 Feb; 36(2):144-8. PubMed ID: 11252405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical structure of bismuth compounds determines their gastric ulcer healing efficacy and anti-Helicobacter pylori activity.
    Sandha GS; LeBlanc R; Van Zanten SJ; Sitland TD; Agocs L; Burford N; Best L; Mahoney D; Hoffman P; Leddin DJ
    Dig Dis Sci; 1998 Dec; 43(12):2727-32. PubMed ID: 9881506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siderophore production and iron-regulated envelope proteins of Helicobacter pylori.
    Illingworth DS; Walter KS; Griffiths PL; Barclay R
    Zentralbl Bakteriol; 1993 Sep; 280(1-2):113-9. PubMed ID: 8280932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloantibiotics: synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter pylori.
    Shaikh AR; Giridhar R; Megraud F; Yadav MR
    Acta Pharm; 2009 Sep; 59(3):259-71. PubMed ID: 19819823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective and effective bactericidal activity of the cobalt (II) cation against Helicobacter pylori.
    Bruggraber SF; French G; Thompson RP; Powell JJ
    Helicobacter; 2004 Oct; 9(5):422-8. PubMed ID: 15361081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bismuth-Induced Inactivation of Ferric Uptake Regulator from Helicobacter pylori.
    He X; Liao X; Li H; Xia W; Sun H
    Inorg Chem; 2017 Dec; 56(24):15041-15048. PubMed ID: 29200284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Hpn and NixA of Helicobacter pylori in susceptibility and resistance to bismuth and other metal ions.
    Mobley HL; Garner RM; Chippendale GR; Gilbert JV; Kane AV; Plaut AG
    Helicobacter; 1999 Sep; 4(3):162-9. PubMed ID: 10469190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remarkable in vitro bactericidal activity of bismuth(III) sulfonates against Helicobacter pylori.
    Andrews PC; Busse M; Deacon GB; Ferrero RL; Junk PC; MacLellan JG; Vom A
    Dalton Trans; 2012 Oct; 41(38):11798-806. PubMed ID: 22903621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bismuth-mediated disruption of the glycocalyx-cell wall of Helicobacter pylori: ultrastructural evidence for a mechanism of action for bismuth salts.
    Stratton CW; Warner RR; Coudron PE; Lilly NA
    J Antimicrob Chemother; 1999 May; 43(5):659-66. PubMed ID: 10382887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori.
    Ge R; Sun X; Gu Q; Watt RM; Tanner JA; Wong BC; Xia HH; Huang JD; He QY; Sun H
    J Biol Inorg Chem; 2007 Aug; 12(6):831-42. PubMed ID: 17503094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of iron-repressible outer membrane proteins in Helicobacter pylori and its association with iron deficiency anemia.
    Lee JH; Choe YH; Choi YO
    Helicobacter; 2009 Feb; 14(1):36-9. PubMed ID: 19191894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bismuth and nitecapone on acetaldehyde production by Helicobacter pylori.
    Salmela KS; Roine RP; Höök-Nikanne J; Kosunen TU; Salaspuro M
    Scand J Gastroenterol; 1994 Jun; 29(6):528-31. PubMed ID: 8079111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.